Detailed market commentary at The Market Ticker and Ticker Classics
(The Year 2012 In Review)
Donations accepted; we offer GOLD ACCESS for enhanced privileges. T-Shirts, caps, coffee mugs? Click here.
BlogTalkRadio - Mondays at 3:30 Central - Yes, TickerGuy has a radio show (kinda)
RSS available You are not signed on; if you are a visitor please register for a free account!
|MarketTicker Forums Single Post Display (Show in context)||
User: Not logged on
|User Info||Intellectual Property; entered at 2011-05-22 19:00:15|
In particular, medical devices and pharmaceuticals should be available without excessive costs related to licensing as they are in other countries.
Wrong. This is a marketing and pricing issue, not an intellectual property problem. The inventor and assignee have the right to apply the derivative value of any intellectual property in a cost as they see fit in a free market.
The problem here is the FDA regulations which have been primed to favor pharmaceutical companies and how they abuse the American people. If they allowed individuals within the US borders to buy products outside US borders, then the difference between prices within the US and outside would disappear in an instant. Unfortunately when Internet pharmacies sprung up in Canada and it became known that people near the border could cross the border and buy the same medication (sometimes coming from the same lot) for a much cheaper price, the FDA shut it down. There is no free market in pharmaceuticals due to pharmaceutical industry lobbying.
One could potentially fix the problem by forcing unitary pricing of patents across all geographies, but that's then not a free market.